Torben Bjerregaard Larsen

1959 -

صورة من قبل: Wikimedia Commons

بلد المواطنة: الدنمارك

تعلَّم في: جامعة آرهوس

المهنة: باحث, كبير الأطباء, أستاذ جامعي

الموقع الرسمي: vbn.aau.dk/en/persons/torben-bjerregaard-larsen(a3c6747f-b9db-488b-8eb9-887d38742880).html

سلسلة

There is nothing here

Create a new serie

أعمال

There is nothing here

Create a new work

مقالات 182

Date

العنوان

الكاتبون

2020-01-31

Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: A descriptive nationwide cohort study

Line Melgaard, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip
2020-01-31

Twenty-year time trends in use of evidence-based heart failure drug therapy in Denmark

Nicklas Vinter, Torben Bjerregaard Larsen
2020-03-20

Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes without Cardiovascular Disease: A Danish Cohort Study

Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip, Peter Brønnum Nielsen, Mia Vicki Fangel
2020-04-10

Extended oral anticoagulation after incident venous thromboembolism - a paradigm shift?

Ida Ehlers Albertsen, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Piazza, Mette Søgaard
2020-04-21

Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study

Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip, Peter Brønnum Nielsen, Flemming Skjøth, Søren Due Andersen, Mette Søgaard
2020-05-05

Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study

Ida Ehlers Albertsen, Thure Filskov Overvad, Torben Bjerregaard Larsen
2020-06-23

Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study

Line Melgaard, Thure Filskov Overvad, Gregory Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
2020-07-04

Should we reintroduce previous venous thromboembolism into decision-making for anticoagulation in atrial fibrillation? Insights from a nationwide cohort

Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip, Flemming Skjøth, Ida Ehlers Albertsen, Mette Søgaard
2020-09-10

Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives

Torben Bjerregaard Larsen, Peter Brønnum Nielsen, Thure Filskov Overvad, Ida Ehlers Albertsen, Anette Arbjerg Højen, Mette Søgaard
2019-05-01

Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study

Peter Brønnum Nielsen, Jette Kolding Kristensen, Martin Bach Jensen, Gregory Lip, Torben Bjerregaard Larsen, Thure Filskov Overvad, Mia Vicki Fangel
2019-04-01

Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Peter Brønnum Nielsen, Mette Søgaard, Gregory Lip, Torben Bjerregaard Larsen, Jette Nordstrøm Kjældgaard, Flemming Skjøth
2019-02-14

Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study

Mette Søgaard, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth
2019-05-29

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study

Mette Søgaard, Peter Brønnum Nielsen, Gregory Lip, Torben Bjerregaard Larsen, Jette Nordstrøm Kjældgaard, Flemming Skjøth
2019-05-14

Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study

Anette Arbjerg Højen, Mette Søgaard, Deirdre A Lane, Torben Bjerregaard Larsen
2019-01-01

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study

Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Lip, Line Melgaard, Flemming Skjøth
2019-10-10

Predictors of Not Initiating Anticoagulation After Incident Venous Thromboembolism: A Danish Nationwide Cohort Study

Ida Ehlers Albertsen, Peter Brønnum Nielsen, Mette Søgaard, Torben Bjerregaard Larsen, Thure Filskov Overvad, Samuel Z. Goldhaber, Gregory Piazza
2019-10-10

Evaluation of the C2HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study)

Flemming Skjøth, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Gregory Lip
2019-11-27

Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish nationwide cohort

Peter Brønnum Nielsen, Mette Søgaard, Torben Bjerregaard Larsen, Gregory Lip, Flemming Skjøth
2019-12-17

Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study

Peter Brønnum Nielsen, Mette Søgaard, Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip, Flemming Skjøth, Søren Due Andersen
2018-01-31

Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study.

Flemming Skjøth, Gregory Lip, Thure Filskov Overvad, Torben Bjerregaard Larsen, Line Melgaard
2018-02-01

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?

Gregory Lip, Thure Filskov Overvad, Peter Brønnum Nielsen, Flemming Skjøth, Torben Bjerregaard Larsen
2018-02-21

Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism

Mette Søgaard, Peter Brønnum Nielsen, Flemming Skjøth, Torben Bjerregaard Larsen, Jette Nordstrøm Kjældgaard, Craig I Coleman
2018-10-01

Torben Bjerregaard Larsen
2018-10-15

Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review

Elin Danielsen Lunde, Peter Brønnum Nielsen, Sam Riahi, Torben Bjerregaard Larsen, Kirsten Fonager, Albert Marni Joensen, Gregory Lip
2018-10-25

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation

Flemming Skjøth, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Thomas Decker Christensen, Erik Lerkevang Grove
2018-09-17

Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study

Flemming Skjøth, Søren Pihlkjær Hjortshøj, Sam Riahi, Gregory Lip, Torben Bjerregaard Larsen, Henrik Vadmann
2018-03-22

Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban

Peter Brønnum Nielsen, Torben Bjerregaard Larsen, A. John Camm, Craig I Coleman
2018-10-01

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study

Peter Brønnum Nielsen, Bo Christensen, Martin Bach Jensen, Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip
2018-07-01

Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?"

Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Thure Filskov Overvad
2018-08-21

Sex differences in risk of incident venous thromboembolism in heart failure patients

Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Thure Filskov Overvad, Gregory Lip, Line Melgaard, Flemming Skjøth
2018-09-01

Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study

Ida Ehlers Albertsen, Peter Brønnum Nielsen, Mette Søgaard, Torben Bjerregaard Larsen, Thure Filskov Overvad, Samuel Z. Goldhaber
2017-12-06

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, E

Joao Morais, Gregory Lip, Tatjana S Potpara, Deirdre A Lane, Laurent Fauchier, Torben Bjerregaard Larsen, Francisco Marín, Giuseppe Boriani, Jean-Philippe Collet, Calambur Narasimhan, Brian Olshansky, Luc Pierard, Karen Sliwa, Gonzalo Varela, Gemma Vilahur, Bianca Rocca

Human - wd:Q38543743

أهلًا وسهلًا إلى آنڤانتير

مكتبة أصدقائك ومجتمعاتك

تعلم المزيد